Gut, 2017-05, Vol.66 (5), p.980-982
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating
- Ist Teil von
- Gut, 2017-05, Vol.66 (5), p.980-982
- Ort / Verlag
- England: BMJ Publishing Group LTD
- Erscheinungsjahr
- 2017
- Beschreibungen/Notizen
- Of note, however, placebo response rates in similar IBS patient cohorts are reported to be approximately 37.5%, which is considerably lower than the response rate of 75% that we report here. 8 Nonetheless, double-blind, placebo-controlled trials, addressing also microbial changes, are necessary to provide clear answers about the applicability of FMT in IBS and are currently on-going both in our centre ( NCT02299973 ) and elsewhere ( NCT02092402 ; NCT02154867 ). Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohn Colitis 2016; 10: 387-94. doi:10.1093/ecco-jcc/jjv203 8 Shah E, Pimentel M. Placebo effect in clinical trial design for irritable bowel syndrome.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0017-5749eISSN: 1468-3288DOI: 10.1136/gutjnl-2016-312513Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5531219
- Format
- –
- Schlagworte
- Abdomen, Clinical trials, Colitis, Diet, Inflammatory bowel diseases, Intestine, Irritable bowel syndrome, Microbiota, Patients, Placebos, PostScript, Response rates, Species richness, Transplantation